The Los Angeles Biomedical Research Institute (LA BioMed) and BioLabs, a network of shared lab facilities designed to manage all aspects of operations for high-potential, early-stage life science companies, today announced the Spring 2019 opening of a new Los Angeles incubator.
The BioLabs LA BioMed innovation center will accommodate up to 30 new companies and is uniquely designed to help startups go further and faster on limited capital investment.
BioLabs LA BioMed is:
- Located at a 78,000-square foot, $65 million research building at LA BioMed next to the Harbor-UCLA Medical Center in Torrance;
- An 18,000-square foot facility that offers users access to state-of-the-art lab and office facilities, more than $1 million in shared equipment, and world-class programming and events from world-class programming and events from LA BioMed’s distinguished roster of more than 400 researchers, several of whom have launched their own startups; and
- Premium co-working space that is designed to scale to a company’s growth, whether a single lab bench or a suite of offices.
BioLabs LA BioMed is currently accepting applications for bioscience startups for the Spring 2019 term.
As with all BioLabs sites, the Los Angeles innovation center is designed by a team of scientists and entrepreneurs with decades of experience in business formation and startup success.
“The biotech ecosystem in Los Angeles is experiencing unprecedented growth, and we are thrilled to be working with the County of Los Angeles, BioLabs, and other stakeholders to offer this premium space for early-stage companies,” said Keith B. Hoffman, Ph.D., Vice President of Business Development and Technology Transfer, LA BioMed. “With its excellent reputation and impressive track record, BioLabs is our partner of choice. Together, we hope to help drive the rapid growth of bioscience startups in the Los Angeles ecosystem.”
The innovation centers offer flexible, fully-equipped and permitted shared lab and office spaces with inspired designs that foster interaction and collaboration. The centers also provide concierge service as well as technical and administrative support.
BioLabs LA BioMed is part of BioLabs’ growing network of facilities, which includes locations in San Diego, Calif., Raleigh-Durham, N.C., Princeton, N.J., Boston and Cambridge, Mass.; the San Francisco Bay Area, Calif.; Philadelphia, Pa. and New York, N.Y.
“LA BioMed has been able to attract a roster of highly innovative companies, who will help make BioLabs LA BioMed the premier space for a biotech startup to launch, grow, and create new job opportunities,” said Johannes Fruehauf, M.D. Ph.D., President and CEO, BioLabs.
LA BioMed is an incubator of innovation with a global reach and a 66-year reputation of improving and saving lives. Driven by the positive social impacts of breakthrough therapies, the Southern California-based research institute and incubator – with over 100 principal investigators (PhDs, MDs and MD/PhDs) working on over 600 research studies, including therapies for multiple orphan diseases – is an essential element to one of the nation’s top-ten biotech clusters.
“The BioLabs LA BioMed location will build upon our success in Southern California, where we opened a site in 2016 that is now 100 percent occupied, as well as in other geographies,” commented Susie Harborth, Chief Operating Officer of BioLabs, “The BioLabs LA BioMed site was designed to enable collaboration among like-minded startups, and we hope it will be an attractive home for both domestic and international companies who want to have a presence in the Los Angeles market.”
BioLabs is a membership-based network of shared lab facilities located in the nation’s key biotech innovation clusters, designed exclusively for high-potential, early-stage life science companies. It offers co-working environments that pair premium, fully-equipped and supported lab and office space with unparalleled access to capital and industry partners. This fertile, supportive ecosystem allows nascent companies to shift their focus from startup operations to innovation so they can reach their scientific potential quickly and achieve business success. Companies can start with a single bench, and scale up as they grow.
For more information contact: Kevin Byrum – email@example.com – 310.414.9040 x114